Teva Pharmaceutical Indus (NYSE:TEVA) is set to give its latest quarterly earnings report on Wednesday, 2026-01-28. Here's what investors need to know before the announcement.

Analysts estimate that Teva Pharmaceutical Indus will report an earnings per share (EPS) of $0.63.

Investors in Teva Pharmaceutical Indus are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Performance in Previous Earnings

In the previous earnings release, the company beat EPS by $0.11, leading to a 0.57% drop in the share price the following trading session.

Here's a look at Teva Pharmaceutical Indus's past performance and the resulting price change:

Performance of Teva Pharmaceutical Indus Shares

Shares of Teva Pharmaceutical Indus were trading at $32.14 as of January 26. Over the last 52-week period, shares are up 73.71%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Teva Pharmaceutical Indus visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.